September 16, 2009 09:00 AM Eastern Time

MMP Portfolio™ Prevails After Multiple Reexams

CUPERTINO, Calif.--(BUSINESS WIRE)--Alliacense announced today that the USPTO has affirmed the validity of US’336, the most widely recognized patent in the MMP Portfolio™.

“These developments obviously diminish any uncertainties associated with purchasing the required MMP Portfolio license, and will thus have a direct impact on the market price going forward.”

The TPL Group has extended its remarkable string of successes against multiple validity attacks on the MMP Portfolio perpetrated by numerous electronics industry giants from around the world. These victories significantly strengthen the MMP Portfolio patents – and accordingly, magnify the risk for those companies without a license to the technology. Recent key victories include:

• August - September 2009. The USPTO indicates it will issue a Reexamination Certificate for the US’336 “Dual Asynchronous Clock” patent, ending reexaminations filed by NEC, Toshiba, and the Public Patent Foundation; and resoundingly rejects another attempted attack by litigant HTC.
• July 2009. The USPTO issues a Reexam Certificate for the US’584 “Multiple Instruction Fetch” patent over the reexaminations filed by litigants NEC and Toshiba.
• January 2009. The German Patent Court confirms the validity of MMP Portfolio™ patent EP’730 rejecting a “nullity action” brought by Deutsch Telecom.

“This remarkable story demonstrates,” said Mac Leckrone, President of Alliacense, “that the reexam delay tactic routinely encouraged by lawyers defies business sense, since it usually backfires by strengthening the very patents under attack.”

Combined with favorable “Markman” Rulings in the Eastern District of Texas in 2007, and the steady addition of over 60 licensees since the launch of the Licensing Program in 2005, the MMP Portfolio™ continues its phenomenal ascendance as one of the most important patent portfolios in the history of electronics.

Mike Davis, Senior Vice President of Licensing, added, “These developments obviously diminish any uncertainties associated with purchasing the required MMP Portfolio license, and will thus have a direct impact on the market price going forward.” Davis also confirmed that progressively higher royalty rates remain a basic principle of the MMP Portfolio Licensing Program.

About the MMP Portfolio™

The Moore Microprocessor Patent Portfolio contains intellectual property that is jointly owned by the privately-held TPL Group and publicly-held Patriot Scientific Corporation (OTCBB: PTSC). The MMP Portfolio includes seven U.S. patents as well as their European and Japanese counterparts. It is widely recognized that the MMP Portfolio™ protects fundamental technology important to the entire spectrum of microprocessor-based products, including consumer electronics, medical devices, automobiles and aerospace and defense systems. Manufacturers can learn more about how to participate in the MMP Portfolio™ Licensing Program by contacting: mmp-licensing@alliacense.com.

About Alliacense

Alliacense is a TPL Group Enterprise executing best-in-class design and implementation of Intellectual Property (IP) licensing programs. As a cadre of IP licensing strategists, technology experts, and experienced business development/management executives, Alliacense focuses on expanding the awareness and value of TPL’s IP portfolios. Founded in 1988, The TPL Group has emerged as a coalition of high technology enterprises involved in the development, management and commercialization of proprietary product technologies as well as the design, manufacture and sales of proprietary products based on those technologies and corresponding IP assets. For more information, visit www.alliacense.com.

Alliacense and MMP Portfolio™ are trademarks of The TPL Group. All other trademarks belong to their respective owners.